Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00490256 · ClinicalTrials.gov registry record · NA

Modified Perfusion for Neonatal Aortic Arch Reconstruction

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT00490256 is a NA study that has completed, run by Emory University. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00490256, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

Even though the lower part of the body does receive some blood supply during Cardiopulmonary Bypass(CPB) surgery, it may not be enough. As a result of this lowered blood supply, there are complications associated with CPB and clamping of the aorta. These include complications with the stomach, intestines and kidneys. The hypotheses of this study are that increased lower body perfusion during aortic arch reconstruction will decrease intestinal ischemia and the incidence of necrotizing enterocolitis, improve renal function in the postoperative period, and shorten both intensive care unit and hospital length of stay. The purpose of this research study is to provide the lower part of the body and its organs with possibly more blood supply with a modified form of cardiopulmonary bypass and see if this additional blood supply helps to decrease complications of the kidney, stomach and intestines.

Interventions

  • PROCEDURE Modified Selective Cerebral Perfusion

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2007-06
Est. Completion 2010-06
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT00490256

The ClinicalTrials.gov registry entry for NCT00490256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Modified Selective Cerebral Perfusion is the first listed.

NCT00490256 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00490256 about?

NCT00490256 is a clinical study titled "Modified Perfusion for Neonatal Aortic Arch Reconstruction". Even though the lower part of the body does receive some blood supply during Cardiopulmonary Bypass(CPB) surgery, it may not be enough. As a result of this lowered blood supply, there are complications associated with CPB and clamping of the aorta. These include complications with the stomach, intes...

What is the current status of trial NCT00490256?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2007-06. Estimated completion is 2010-06.

What interventions are being tested in trial NCT00490256?

The interventions under investigation include: Modified Selective Cerebral Perfusion (PROCEDURE).

Who is sponsoring clinical trial NCT00490256?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.